INTRODUCTION
The importance of understanding the antigenic structure of a virus is usually associated with the need to identify immunogenic properties of its component pro teins, with a view to production of vaccines which afford protection to susceptible animals. Care must be taken when translating antigenic properties of virus proteins, and their immunogenic properties measured in vitro, to the situation in an infected animal. Protection may be related to such in vitro properties, but they may not pro vide the whole story, since the dynamics of binding between virus and antibodies measured in vitro may not be the same as in animals. The large variation in animals within and between species in terms of recognition of antigenic regions of viruses also influences the mechanisms of protection mediated by antibody.
FMD viruses are members of the Picornaviridae, which immediately defines their size range (22-30 nm diameter) and has implications for the possible binding characteristics of antibodies. FMD viruses are acid labile and replicate at a high rate at the sites of infection. Serologically, they form a complex group of 7 serotypes where infection with one serotype confers immunity against reinfection with the same serotype but not the others. This dogma is not entirely validated, since very few intertypic cross-protection studies have been carried out in animals. Most viru ses are typed serologically using serum against standard type strains. Within each of the serotypes there are many subtypes defined by a variety of serological assays including virus neutralisation (VN) tests, and by the use of many different antisera.
-300 -The subtypes may be very different: type A 22 does not confer immunity to type A 5 virus, and vice versa. The clear division into serotypes is further muddied since the population of viruses from any source must be regarded as a heterogeneous mixture of stable mutants. Thus methods used to study FMD virus which rely on passage in tissue culture may well be influenced by selection of particular mutants. This selec tion may be different from that in the animal which the heterogeneous population infects, so that results from serological and molecular biological studies on tissue culture derived virus(es) may not provide a reliable indication concerning immunity in the host animal.
STUDIES OF ANTIGENIC STRUCTURE
These may be divided conveniently into serological and molecular biological studies, which should, of course, complement each other. Table I illustrates the current knowledge concerning the FMD antigens which are produced during the infectious cycle in tissue culture. All the components described are antigenic as determined by their isolation, purification and injection into a wide variety of animal species. In the case of the 146S particle, it appears that its integrity is essential for the formulation of success ful inactivated vaccines so that a protective response is initiated. Subunits, although they share antigenic sites with whole virions, are not as immunogenic. Empty par ticles, by contrast, appear to be immunogenic and, where examined in the type A viruses, appear also to elicit similar protective responses to whole particles. The VIA antigen is produced in infected cells and animals and is antigenic so that infec ted animals produce large amounts of antibodies which show inter-typic in VIA cross-reactivity.
Most studies have implicated VP1 as the protein responsible for antigenic varia tion of FMD virus. This is not too surprising since work with denatured proteins indicates that only VP1 (not VP2 and VP3) produces antibodies which can bind to virus and neutralise, and since VP1 alone can confer protection in animals. The search for antigenic peptides stemmed from these observations, and the possibility of peptide vaccines has stimulated a large research input which is being maintained with varying approaches, based on rather subjective grounds. This will be reconsi dered later.
Recent research
Using monoclonal antibodies, specific reactions between antigen and antibody can now be quantified and then related to functional properties in vitro and in vivo. Binding of antibody can be related to amino-acid sequences and to exact structural properties as determined from X-ray crystallographic data. In the case of FMD, we are waiting for the latter, but we have available structural models for polio virus and rhino virus from which the sequence data for FMD viruses may be roughly translated into 3-dimensional relationships of the virion proteins. The "important" epitopes may therefore be defined so that rules of objectivity in vaccine design, in stead of subjective trial and error exercises, may be formulated. However, in addi tion to this, we need a background of work on the nature of immunological respon ses in the cow. Alternative animal experimental systems may give false antigenic/immunogenic/protective data even when faced with the same antigen repertoire of the virus, a fact that is becoming increasingly relevant to investiga tions of the use of defined peptides. For example, good immunogenic and protec tive responses may be obtained in guinea pigs, but only good antigenic and immu nogenic (in vitro) responses in cows, with little or no protection!
Observations on the structure of FMD viruses
FMD viruses show icosahedral symmetry and have a size range from about 22 to 30 nm diameter as judged from electron micrographs. Considerable variation has been noted even for the same virus sample under different conditions, such as high molarities. This suggests considerable flexibility in the capsid protein interactions. Such flexibility may be responsible for alteration of binding of antibodies, as obser ved by the greatly differing binding of MAbs to the same virus under different assay conditions. Different characteristics have been demonstrated for binding to virus directly absorbed to plastic, to virus trapped via an antibody attached to plas tic and virus reacted in the liquid-phase. In each case the integrity of the par ticle was maintained. Polyclonal antisera against denatured VP1, 2 and 3 also behave differently on virus directly attached to plastic as opposed to liquid-phase assays. Only anti-VP 1 serum reacts with the virus in liquid-phase whereas all three antisera react with solid-phase attached virus. This suggests alteration of sites, pre sumably due to physical changes in the capsid effecting conformational changes caused by alterations in the exact juxtaposition of adjacent proteins and may have implications in the effects of any physical treatment of the virus which may be most pertinent to vaccines. For example, vaccines are normally formulated so that virus is attached to a solid phase. Detection of antigenic changes in such viruses actually in the vaccine formulation is probably impossible; elution of the virus leads to fur ther complications due to the physical and chemical rationale involved. Although the effect of physical changes altering some epitopes need not be exaggerated, the evidence from the use of MAbs suggests that important antigenic/immunogenic and protection-inducing sites can be altered by physical treatments as indicated above. These differences are difficult to measure using polyclonal antisera which contain heterogeneous populations of antibodies.
The effect of lowering the pH to around 6.5, or heating the virus to 56°C for a few minutes provides an extreme physico/chemical treatment contrasted with the treatments above. Here 12S subunits are released which share some specificity with the whole particle, but which have unique determinants both on the external (VP1, 2 and 3 previously externally situated on the outside of the capsid) and internal faces. The relationship of the 12S subunits in the 146S particle is shown in Fig. 1 . Comparison of the binding of MAbs to 12S and 146S illustrates all these reactivi ties. They also show that there are conformational changes in antigenic sites of the 12S subunits represented as reduced but not total elimination of binding of MAb, but these are not easily demonstrated using polyclonal antisera. The exact differen ces in the antigenic structure of the 12S to 146S may partly explain their different immunogenicities. The binding affinity of antibodies as well as the exact antigenic site has been found to be essential to provide protection of animals through effi cient opsonisation mechanisms. The 146S binding antibodies generated against 12S may be of lower affinity and fail to activate opsonisation and hence "clearance" of virus in the animal. This is probably not the whole story since the presentation and subsequent processing of the smaller 12S subunits may well be different from that for 146S.
Before crystallographic data were available, attempts to determine the relation ships of VP1, 2 and 3 were made by iodination studies (degree of externalisation of proteins) and chemical linkage studies. Iodination shows that when labelling "fresh" virus immediately from sucrose gradients, only VP1 and trace VP2 is label led (chloramine T). However, incubation of the virus at 37°C for 1 hour, storage of virus at 4°C overnight or even at -70°C for 1 month, causes all three proteins to be labelled. Again this suggests considerable alteration of the virus structure as indicated by serological studies.
Even without crystallographic data, the geometric arrangement of the proteins and their relationship in the virion can be represented (Fig. 2) . The number of unique sites within each pentamer and between each pentamer is obvious. Fig. 3 shows the relative size of the 146S particle to an IgG molecule, a fact often not con sidered when attempting to examine antibody binding. The nature of antibody binding to FMD virus can now be examined in terms of: a) the identification of epitopes (continuous, discontinuous), "major antigenic sites" on the virion; b) the relationship of similar epitopes on the virion (spatial distance and orienta tion); Most of the data come from the examination of the binding of MAbs which are unique populations of single affinity antibodies. However, polyclonal responses produce antibodies which not only react with different sites, but also react with individual sites with a heterologous population of antibodies. Any test which mea sures the binding and subsequent effect of that binding of polyclonal antisera is a result of the population dynamics (competition of antibodies) of the heterogeneous antibodies in the serum (avidity). Thus MAbs may highlight possible antigen/antibody reactions of relevance in the polyclonal situation which cannot be elucidated using heterogeneous mixtures of antibodies.
FIG. 1 Relationship of pentameric (12S) subunits in FMD virions
Numbers 1 to 9 show the proteins composing individual pentamers.
FIG. 2 Relationship of major structural proteins in FMD virion
VP1, VP2, VP3 represent major structural proteins, thick lines represent the borders of adjacent pentamers. The icosahedral symmetry of FMD virions imposes restrictions on the bivalent binding of antibodies. It is interesting to examine some possibilities for intra-virion binding of antibodies. The relationship of the pentameric subunits is illustrated in Fig. 1 and the viral proteins VP1, 2 and 3 have been drawn schematically in Fig. 2 . Thus the proteins have a repeating order e.g. VP2-VP1-VP3 around each "apex". Note the alternate interactions of different regions of each protein e.g. VP2-VP3 and VP3-VP2 (different sequences) along the "edges" of the icosahedral model. Alternate interactions at the interface between pentamers take place on different regions of the virus proteins. Basically the proteins in the same pentamer are rota ted 72°, the proteins in adjacent pentamers are on a different "axis". Ignoring con ditions where interviral bridging via antibody occurs (antibody excess), the effect of the geometry on the epitopes can be examined. Two types of antigenic site can be considered, continuous and discontinuous. Figs. 4 , 5, and 6 show continuous epi topes at three different positions on the virion surface. Essentially it does not matter where they are as long as an antibody recognises the amino acid "run" as a linear sequence. Each can be considered as having a position (distance from identi cal epitope) and an orientation. A further complication is that the atomic mobility of the amino acids in the protein must be considered (degree of flexibility of the amino acids). To obtain bivalent binding of antibody the epitopes must be within the limits of binding distance of the paratopes on the Fab (8-15 nm -optimum distance 10 nm, dependent on the exact IgG isotype), as determined by the flexibi lity of the hinge region. The epitopes must also have the correct relative orientation so that the Fabs bind with a left and right handedness. The Fab combining region has a limited degree of flexibility to allow for some degree of difference in orienta tion of the epitopes, but this must be regarded as small ; however, it may be of rele vance in understanding the effects on the virion after interaction of some molecules of antibody. Fig. 4 shows a linear epitope sited on VP1 (centrally). The letters a, b and c are used to denote the amino acid run recognised by the paratope of an antibody. Biva lent binding between site A can be considered theoretically. Thus for interactions within the same pentamer A-B is unlikely as they are too close, A-C is possible, A-D is possible, and A-E is too close. For inter-pentameric binding, A-F, A-G, A-H, are all possible in terms of the distance between the epitopes. A-I, J and K are un likely in terms of the distance apart (note that the interactions of site B are similar to those of A except that epitopes of a different relative position are involved e.g. B-I is equivalent to A-G, C-J etc. Close examination of the relationships of the amino acids shows that we must consider the "sidedness" of the run. Thus, for example, although we have the correct order of amino acids in C as A, the exact orientation of the molecules in the protein at C is not identical to that recognised by the paratope in an antibody molecule bound at A. However, we do see the handed ness of amino acids required for bivalent binding with sites at F, G and H. The most likely binding, therefore, occurs between A-F and A-G (A-H is probably too far). Under optimum conditions for the binding of MAbs for epitopes such as shown (large virus-virus distances in assays to avoid inter-virus bridging, molar equivalent of virus and antibody), antibody most probably binds either A-G, A-F or as a combination of both. Thus it is possible to calculate the maximum number of molecules of antibody which can attach under these conditions bivalently, while accounting for the steric inhibition of binding such as A-G inhibiting B-F, and also assuming the possibility of potentially bivalent MAbs reacting monovalently with free epitopes. The answer is 30 bivalently attached molecules for A-G with no free epitopes, and 20 bivalently attached molecules for A-F with 20 free epitopes (possi bility of 40 molecules per virion).
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FIG. 4 Theoretical antigenic sites on VP1 of FMD virions
Site with amino acids a, b, c situated centrally on VP1.
Letters A to K indicate similar sites on pentamers with different orientation and symmetry. Fig. 5 illustrates the effect of altering the distance between the epitopes on the virion. The linear site a, b, c is placed near to the vertices. Here the "handedness" requirements still pertain and the orientation of the epitopes is similar to those in example 1. However, the intra-pentameric distance between the epitopes is now much reduced, precluding the interaction of A with B, C, D and E ; and the interpentameric distance is large, e.g. sites on A-F, precluding bivalent interaction. Thus the chances of bivalent binding of MAb will be reduced, the nearer the epitopes are situated towards the apices of the virion. Under these conditions the bivalent mole cules can bind monovalently and theoretically 60 molecules could bind. This num ber could be reduced owing to the steric hindrance at the apices of 5 molecules reac ting with closely arranged epitopes. Fig. 6 shows an epitope situated close to the pentameric boundaries. The intrapentameric interactions are unlikely to be due to their handedness differences, and epitopes appearing at the boundaries are too close for inter-pentameric interac tions. The most likely interactions are A-X or L (less likely due to distance and orientation). Note that this A-X inter-pentameric bridge is different from those above. The maximum number of antibody molecules reacting with the virion is 20. Fig. 7 shows an epitope composed of amino acids from 2 peptides and illustrates the effect of the "handedness" required for binding to conformational determi nants. The site is placed "centrally" between VP1 and VP3, and the amino acids recognised by the paratope are c and f. Fig. 8 also shows a similar situation where the epitope has been represented diagrammatically. Some examples of the required epitope orientation and "handed ness" are also illustrated. Examination of likely bivalent interactive identical epi topes shows that none exist! Support for this theoretical treatment of virus structu ral proteins is available from MAb binding data. The reduced likelihood of bivalent binding to conformational sites on the same virus particle is interesting when consi dering the functional consequences of antibody binding at low virus, low antibody concentrations in vitro and particularly in vivo. Binding data for the MAbs can be related to the effect of the binding (such as neutralisation and protection); different conditions (molar ratios of virus to MAb) can alter these effects dramatically. The alterations can be partly explained using the reasoning above. Exact location of the epitopes on the virion surface at the amino acid level and localisation of the amino acids in a 3-dimensional map will clarify the problem. Two epitopes "mapped" with reference to the 3-dimensional X-ray diffraction maps of polio support the above ideas.
One prediction concerning the production of anti-peptide vaccines is that the topographical considerations of epitopes must be carefully considered where intra virion bivalent binding is required. Such a requirement may be essential to produce enhancement of typically in vitro measured neutralisation, to inhibit generalisation of disease by mechanisms outlined below, such as opsonisation.
Biological implications
The consequences of the MAb binding can be examined in vitro and in vivo. Certain MAbs can neutralise virus after reaction with specific sites, while others binding at different sites do not. Generally any neutralisation observed by combina tion with MAb and then titration in tissue culture also gives protection in mice from and VP3 at the edge of each pentamer. Letters A to X show similar sites on pentamers. Binding to amino acids c and f dominant. Letters A to K show similar sites on each pentamer.
FIG. 8 Theoretical antigenic sites on FMD virion
Diagrammatic representation of antigenic sites situated between VP1 and VP2.
Letters A to K show similar sites on each pentamer. Examples of epitopes which allow bivalent binding of IgG are shown. lethal challenge to homologous virus. However, close study of the exact relationship of the ratio of virus to antibody indicates that certain MAbs can greatly increase the protection in mice. Basically, much lower numbers of antibodies binding to virus than are necessary for in vitro neutralisation will produce protection by opsonisation in the animal. Complexes which are infectious in cells are noninfectious in animals. The process of opsonisation and the detection of specific antigenic targets is proving extremely interesting and studies are being extended into cattle. The intactness of the immunoglobulin is essential in these processes ; Fab fragments do not function although they bind to the appropriate sites.
The independence of the serologically identifiable antigenic sites is confirmed by studies using mutants generated by MAb antibody pressure. Amino acid sequence data on such mutants also offer the chance to evaluate the structural implications of the amino acid changes which, in turn, can be correlated to cross-protection data. Such information is critical in understanding the relevance of epitopes in the field situation, since it is simple enough to identify the presence of such epitopes in field samples using MAb panels. This may lead to the immediate "sub-typing" of field strains with a predictive element concerning the relationship of the strain to the likely protection afforded by antibodies against a vaccine strain. Such studies are being actively made through the production of MAb panels against many vaccine strains and their characterisation and evaluation in immunoassays which best measure the parameters mentioned above.
CONCLUSIONS
From this rather widely ranging examination of the antigenic structure of FMD viruses, it is obvious that we are on the cross-roads of the serological/biochemical approaches and the understanding of the immunology of the disease. This is in common with many other studies of virus diseases. New technologies have highlighted the need to reappraise data in some fields of research, as for example the need to understand the responses to defined peptides found in antigenic sites. The main areas for future research include :
(i) The better understanding of immune reactions by examination of antigen presentation and processing, T-cell communication in animals and the study of high affinity memory responses.
(ii) The study of enhanced phagocytosis by examination of the affinity ranges of antibodies and the importance of specific sites.
(iii) The study of anti-idiotope vaccines (artifical epitopes) and the role of idiotope networks in the animal. Methods are now available to solve the molecular basis of virus/cell interactions, and I look forward to the results of their application in FMDV research as well as in other systems. 
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